Terms: = Pancreatic cancer AND MSI2, ENSG00000153944, 124540 AND Prognosis
4 results:
1. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.
Zhou L; Sheng W; Jia C; Shi X; Cao R; Wang G; Lin Y; Zhu F; Dong Q; Dong M
J Cell Mol Med; 2020 Sep; 24(18):10560-10572. PubMed ID: 32779876
[TBL] [Abstract] [Full Text] [Related]
2. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract] [Full Text] [Related]
3. The Novel KLF4/msi2 Signaling Pathway Regulates Growth and Metastasis of pancreatic cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract] [Full Text] [Related]
4. Proteomic analysis of solid pseudopapillary tumor of the pancreas reveals dysfunction of the endoplasmic reticulum protein processing pathway.
Zhu Y; Xu H; Chen H; Xie J; Shi M; Shen B; Deng X; Liu C; Zhan X; Peng C
Mol Cell Proteomics; 2014 Oct; 13(10):2593-603. PubMed ID: 24997997
[TBL] [Abstract] [Full Text] [Related]
